KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $150.0 million.

  • Abbott Laboratories' Non Operating Income rose 2396.69% to $150.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $568.0 million, marking a year-over-year increase of 7160.12%. This contributed to the annual value of $376.0 million for FY2024, which is 2150.31% down from last year.
  • Per Abbott Laboratories' latest filing, its Non Operating Income stood at $150.0 million for Q3 2025, which was up 2396.69% from $137.0 million recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Non Operating Income peaked at $176.0 million during Q2 2023, and registered a low of -$10.0 million during Q2 2024.
  • In the last 5 years, Abbott Laboratories' Non Operating Income had a median value of $93.0 million in 2022 and averaged $98.3 million.
  • As far as peak fluctuations go, Abbott Laboratories' Non Operating Income soared by 600000.0% in 2021, and later crashed by 10568.18% in 2024.
  • Quarter analysis of 5 years shows Abbott Laboratories' Non Operating Income stood at $63.0 million in 2021, then rose by 7.94% to $68.0 million in 2022, then skyrocketed by 60.29% to $109.0 million in 2023, then surged by 41.28% to $154.0 million in 2024, then fell by 2.6% to $150.0 million in 2025.
  • Its Non Operating Income was $150.0 million in Q3 2025, compared to $137.0 million in Q2 2025 and $127.0 million in Q1 2025.